Additional experiments in NOD/SCID mice looked to evaluate the motion of avatrombopag in vivo. Human fetal liver CD34+ cells have been transplanted into NOD/SCID mice, with human platelets showing four weeks after transplant. Administration of avatrombopag triggered an increase in the creation of human platelets with no acquiring an effect on murin